Search - tctmd.com

Displaying 601 - 620 of 23691

Sort: Relevancy | Date

Presentation TCT 2016

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Presenter: Sripal Bangalore, George D. Dangas, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Optimal Approach to Persistent Type II Endoleaks with Sac Expansion

Presenter: Peter A. Schneider, Barry T. Katzen

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Presenter: Koen Deloose, William A. Gray, Prakash Krishnan

November 01, 2016

Presentation TCT 2016

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Presenter: John A. Ambrose, Peter H. Stone

November 01, 2016

Presentation TCT 2016

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Hasan Jilaihawi

November 01, 2016

Presentation TCT 2016

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics?

Presenter: Stephen Balter, Sanjog Kalra

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto

November 01, 2016

Presentation TCT 2016

Debate: Imaging For TAVR- The Case for TEE and MAC/GA!

Presenter: Patrizio Lancellotti, Sunil V. Mankad, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Presenter: Koen Deloose, William A. Gray, Kenneth Rosenfield

November 01, 2016

Presentation TCT 2016

I Used to Be an Interventional Cardiologist: Psychological Impact

Presenter: David O. Williams, George W. Vetrovec

November 01, 2016

Presentation TCT 2016

Percutaneous Large Bore Access: Technique and Pitfalls

Presenter: Peter A. Schneider, Zvonimir Krajcer

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Presenter: Koen Deloose, William A. Gray, John R. Laird Jr.

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations

Presenter: John D. Puskas, Gregg W. Stone, John S. Douglas Jr

November 01, 2016

Presentation TCT 2016

The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer

Presenter: John A. Ambrose, Peter H. Stone, James E. Muller

November 01, 2016

Presentation TCT 2016

Bioabsorbable Vascular Scaffolds: Landscape in 2016

Presenter: Sripal Bangalore, George D. Dangas, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

Comprehensive CT Algorithm Before TAVR

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, João L Cavalcante

November 01, 2016

Presentation TCT 2016

Overview and Scope of the Problem

Presenter: David O. Williams

November 01, 2016

Presentation TCT 2016

Ethics of Irradiating Patients and Staff

Presenter: Stephen Balter, Charles E. Chambers

November 01, 2016

Advertisement

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Optimal Approach to Persistent Type II Endoleaks with Sac Expansion

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Post-TAVR Valve Thickening: Current Data and Open Questions

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics?

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Debate: Imaging For TAVR- The Case for TEE and MAC/GA!

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

I Used to Be an Interventional Cardiologist: Psychological Impact

Percutaneous Large Bore Access: Technique and Pitfalls

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations

The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer

Bioabsorbable Vascular Scaffolds: Landscape in 2016

Comprehensive CT Algorithm Before TAVR

Overview and Scope of the Problem

Ethics of Irradiating Patients and Staff

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content